Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Jan 29, 2029 (in 870 days)
Similar opportunities open now
- Biological TechnologiesOpenDARPA - Biological Technologies OfficeCloses in 18 days
- Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2029
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $250K
- BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jun 2028Up to $8M
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Same funderOpenNational Institutes of HealthCloses in 48 daysUp to $2.3M
Classification and identifiers
- Solicitation number
- PAR-27-024
- Assistance listing (CFDA)
- 93.859
Amount
Amount not published by the funder
Who can apply
Local government agencies, Small businesses, and Nonprofits, including small and volunteer-run organizations can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
This Notice of Funding Opportunity (NOFO) encourages applications for NIGMS Biomedical Technology Optimization and Dissemination (BTOD) Centers to support late-stage technology optimization and sustainable dissemination of the technologies to the wider biomedical research community. A BTOD Center should be at the leading edge of its field with respect to both technology optimization and engagement with relevant research communities.BTOD projects must address biomedical research areas within the NIGMS mission. Potential applicants are strongly encouraged to consult with NIGMS staff about adherence of their proposed research strategy to the Institute's goals and mission and its responsiveness to this NOFO.